- Home
- THRD vs CURV Comparison
THRD vs CURV Comparison
Compare THRD & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- CURV
- Stock Information
- Founded
- THRD 2019
- CURV 2001
- Country
- THRD United States
- CURV United States
- Employees
- THRD N/A
- CURV N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- CURV Clothing/Shoe/Accessory Stores
- Sector
- THRD Health Care
- CURV Consumer Discretionary
- Exchange
- THRD Nasdaq
- CURV Nasdaq
- Market Cap
- THRD 335.2M
- CURV 402.0M
- IPO Year
- THRD 2022
- CURV 2021
- Fundamental
- Price
- THRD $3.47
- CURV $6.05
- Analyst Decision
- THRD Buy
- CURV Hold
- Analyst Count
- THRD 3
- CURV 4
- Target Price
- THRD $14.00
- CURV $4.33
- AVG Volume (30 Days)
- THRD 1.2M
- CURV 364.3K
- Earning Date
- THRD 03-25-2025
- CURV 03-27-2025
- Dividend Yield
- THRD N/A
- CURV N/A
- EPS Growth
- THRD N/A
- CURV 29.45
- EPS
- THRD N/A
- CURV 0.14
- Revenue
- THRD N/A
- CURV $1,121,714,000.00
- Revenue This Year
- THRD N/A
- CURV N/A
- Revenue Next Year
- THRD N/A
- CURV $0.18
- P/E Ratio
- THRD N/A
- CURV $42.69
- Revenue Growth
- THRD N/A
- CURV N/A
- 52 Week Low
- THRD $3.18
- CURV $2.18
- 52 Week High
- THRD $16.94
- CURV $9.14
- Technical
- Relative Strength Index (RSI)
- THRD 25.71
- CURV 45.82
- Support Level
- THRD $3.18
- CURV $5.95
- Resistance Level
- THRD $3.70
- CURV $6.30
- Average True Range (ATR)
- THRD 0.31
- CURV 0.31
- MACD
- THRD 0.10
- CURV -0.10
- Stochastic Oscillator
- THRD 13.26
- CURV 17.31
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America targeting 27 to 42-year-old women. It is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of e-Commerce platform and stores.